Chinese public health and emergency laws contributed to delayed responses to COVID-19.
Leading scholars from around the world discuss the administrative law and regulatory dimensions to the global response to COVID-19.
The most surprising regulatory dimension of the coronavirus crisis may center on the lifting of rules.
In the United States, disease outbreaks challenge emergency preparedness.
As states legalize marijuana, regulators must determine how to oversee its use.
Two proposed rules aim to improve the rate of organ donations in the United States.
Online announcement declares that new tobacco age restrictions are effective immediately.
FDA’s approval of an Ebola vaccine can serve as a framework for drug development during other epidemics.
Federal regulators seek to expand safe harbors for provider care coordination arrangements.
A proposed law would reduce the amount households spend on health care each year.
Lawyers and regulators are concerned about the lack of regulations for the use of robotic technology in surgeries.
Brazil has recently made efforts to streamline the introduction and distribution of drugs.